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Introduction
Parkinson's disease (PD) is a progressive neurodegenerative disorder that commonly occurs in the elderly, and its prevalence is increasing as life expectancy increases. The three main motor symptoms of the disease are resting tremor, bradykinesia, and rigidity. Additionally, gait and posture alterations can also be manifested [21] . These motor symptoms are associated with the degeneration of melanin-containing dopaminergic neurons, specifically in the substantia nigra pars compacta (SNpc) which decrease the total striatal dopamine (DA) content [10] .
Although PD is commonly classified as a motor disorder, a wide range of early nonmotor symptoms has been detected [4] (e.g., anxiety and depression [2, 23] ). Once the motor symptoms have become apparent in patients, about 60% of dopaminergic cells in the SN have already been lost [28] .
Previous human and animal studies have shown a link between microglial activation and DA neuron loss, suggesting the involvement of inflammation in the pathogenesis of PD [1, 11, 16] . Acting as the initial defense, microglial activation has a crucial role in the neuroprotection; however, its activity can produce proinflammatory mediators, which may result in adverse effects related to the progressive neurodegeneration process [13] . A variety of enzymes are present in activated macrophages, including Nacetylglucosaminidase (NAG), which can be used as marker of macrophage accumulation [20, 29] .
Lesions of the dopaminergic nigrostriatal pathway induced by 6-hydroxydopamine (6-OHDA), which typically induces motor impairment, can lead to behavioral changes that resemble the Fig. 1 . Experimental design to bilateral administration of 6-OHDA into the ventrolateral area of the dorsal striatum. The animals were separated in three distinct groups and tested one, two or three weeks after surgery. In time course experiments, the animals were tested in the open field, plus maze and sucrose preference test, respectively. After the tests, brain dissections were performed to determine the striatal monoamine levels and substantia nigra, striatal and hippocampal NAG levels.
nonmotor symptoms of PD as anxiety-and depression-like response [25, 26] . Additionally, literature shows that 6-OHDA can produce different patterns of immune reactions, like microglial activation [1, 6] .
Since little is known about the progression of early stages of the disease, the use of a model that mimics early PD symptoms can help identify therapeutic targets. Thus, the aim of this study was to investigate the temporal changes related to anxiety-like and depression-like responses, neurochemical alterations, and the innate immune responses, induced by the bilateral 6-OHDA-lesion of the dorsal striatum of rats.
Materials and methods

Animals
Male adult Wistar rats (3 months old) weighing 270-300 g from the colony of the Universidade Federal de Santa Catarina (UFSC) were used. They were housed collectively in plastic cages (5-6 per cage), under controlled temperature (22 ± 2 • C) and a 12 h light-dark cycle (lights on at 7:00 a.m.) with food and water available ad libitum. All the procedures described here were performed in accordance to the guidelines on animal care of the UFSC Ethics Committee on the Use of Animals, which follows the "Principles of laboratory animal care" from NIH.
Intrastriatal injection of 6-OHDA
Thirty minutes before 6-OHDA lesion, all animals were injected with desipramine in order to protect noradrenergic terminals from 6-OHDA toxicity. Bilateral injections of 6-OHDA (12 g on each side) were performed into the ventrolateral area of the dorsal striatum in anaesthetized rats. Details of the surgery are described in Supplementary Data. Testing of the experimental and the control group occurred 7, 14, and 21 days after surgery (see Fig. 1 for a schematic view of the experimental design). A total of 72 rats underwent surgery, where 24 rats (sham, n = 12; 6-OHDA, n = 12) were used in each time group. Animals were sacrificed immediately after the sucrose consumption test.
Open-field test
The open-field test was used to evaluate general locomotor activity. The apparatus consisted of a rectangular box made of wood and covered with impermeable formica (100 cm × 100 cm × 40 cm). Animals (sham, n = 12; 6-OHDA, n = 12) were placed in the openfield for 5 min. The total distance travelled and average speed were determined from the video recordings and analyzed with the ANY-MAZE tracking system (Stöelting Science) [26] .
Elevated plus-maze test
The elevated plus-maze was used to evaluate anxiety-like behaviors. The test was based on the natural aversion of rats for open and elevated areas. The animals (sham, n = 12; 6-OHDA, n = 12) were exposed for 5 min and the anxiety-like behavior was assessed in the elevated plus-maze by measuring the total time spent in open arms and the open arm entries, as previously described [26] . Locomotion was also evaluated on the basis of total arm entries [7] .
Sucrose preference test
Oral sucrose consumption was used as a measure of anhedoniclike behavior. The animals (sham, n = 12; 6-OHDA, n = 12) were transferred to single home cages with free access to food. After 24-h training phase (with two water bottles) to adapt the rats, one bottle was switched to contain 0.8% sucrose solution, and 24 h later, the bottles were reversed, totaling 48-h testing period. The fluid consumption was measured by weighing the bottles. Sucrose preferences were expressed as percent sucrose solution intakes (sucrose solution intake/total intake × 100) [26] .
Monoamine determinations by high performance liquid chromatography (HPLC)
For determining DA, 3,4-dihydroxy-phenylacetic acid (DOPAC), serotonin (5-HT) and 5-hydroxyindoleacetic acid (5-HIAA) contents, striatal tissues from one hemisphere (sham, n = 5; 6-OHDA, n = 5) were removed from skulls on ice, stored in eppendorf tubes containing 0.3 mL of refrigerated buffer (0.1 M perchloric acid and 1.0 mM sodium metabisulfite), and immediately stocked at −80 • C until analysis by HPLC. The detailed conditions for the HPLC analysis are described in Supplementary Data.
Measurement of NAG activity
In order to measure microglial levels, we used an indirect quantification method based on the presence a lysosomal enzyme NAG in macrophages [3, 29] . Striatum and hippocampus from one hemisphere and both substantia nigra, was dissected (sham, n = 5; 6-OHDA, n = 5) together with the samples for HPLC assay. Sample treatment and analytical details are described in Supplementary Data.
Statistical analysis
Differences between groups in all experiments were analyzed by a two-way analysis of variance (ANOVA) with the variables treatment and time followed by the Newman-Keuls test (Statistica ® 6.0, StatSoft Inc., Tulsa, OK, USA). The results are reported as mean ± S.E.M (n equals the number of rats included in each analysis). A value of p < 0.05 was considered significant.
Results
Lesion-induced reduction in locomotor activity
The results of the open-field test in Fig. 2 (left) illustrates the spontaneous locomotor activity of 6-OHDA-lesioned rats. The ANOVA revealed a significant interaction effect of treatment versus time [F(2,66) = 3.553, P < 0.05)] and time [F(1,66) = 2.903, P < 0.05)]. Fig. 2 (right) shows the average speed; ANOVA showed a significant effect for treatment [F(1,66) = 4.597, P < 0.05)] and time [F(2,66) = 3.333, P < 0.05)]. Post hoc analysis revealed that 6-OHDA treatment induced a significant decrease in distance travelled and average speed in relation to all other groups just one week after surgery.
3.2. Anxiety-like behavior induced by 6-OHDA lesion (Fig. 3B) showed a significant effect of treatment [F(1,66) = 38.27, P < 0.001)]. Post hoc analysis showed a significant decrease in the number of entries in all groups lesioned with 6-OHDA. ANOVA of total arm entries (Fig. 3B) revealed a significant effect of treatment [F(1,66) = 5.416, P < 0.05)]. Post hoc analysis (NewmanKeuls) showed a significant difference between treatments only one week after surgery.
Lesion-induced reduction in sucrose preference
The results in Table 1 illustrates the effects of 6-OHDA lesions on sucrose preference, a measure of anhedonic response. ANOVA test showed a significant effect of treatment [F(5,48) = 13.13, P ≤ 0.001]. Post hoc analysis showed that the 6-OHDA treatment significantly decreased preference for sucrose solution at all intervals of time.
Lesion-dependent monoamines changes using HPLC assay
Striatal contents of DA and DOPAC (Fig. 4A ) decreased in all groups treated with 6-OHDA, the ANOVA showed a significant difference for treatment [F(1,24) = 85.20, P < 0.05) and [F(1,24) = 58.67, P < 0.001), respectively]. Further post hoc tests revealed a difference between all 6-OHDA lesioned groups and their respective controls for DA as well as DOPAC. 
Lesion-induced elevated NAG activity
NAG levels in the SN, striatum and hippocampus (Table 2) 
Discussion
Our findings suggest that the partial bilateral lesion of the dorsal striatum by 6-OHDA is able to produce anxiety-and depressionlike effects, consistent with the results of our previous studies [25, 26] . These patterns of responses were maintained at two and three weeks after surgery and therefore can potentially act as a model that mimics the early stages of PD at these time points. The behavioral changes were accompanied by a reduction of DA content in the dorsal striatum, in agreement with previous literature data [5, 26] . Moreover, our results show that 6-OHDA induces elevations in NAG levels in the SN, hippocampus and striatum only at the first week after partial degeneration of nigrostriatal neurons. This increased state of microglial activation in the brain provides evidence that proinflammatory processes could play an important role in PD initiation or progression. To our knowledge no prior study 
Table 2
Effects of intrastriatal 6-OHDA lesion on NAG activities. The values are expressed as mean ± S.E.M of (n = 5). * P ≤ 0.05 compared to the respective sham group (Newman-Keuls post-hoc test).
has examined temporal changes on behavioral, neurochemical, and inflammatory effects on 6-OHDA lesioned rats. The exact mechanisms responsible for anxiety and depressive symptoms in PD are not yet fully elucidated, although DA is one of neurotransmitters that play a role in the etiology and expression of these disorders [8, 27] . Besides, anhedonia, defined as the reduced ability to experience pleasure, is an important feature for the diagnosis of depression and is present in PD [19] . In the present study, 6-OHDA lesion induces an increase in anxiety-and depression-like behavior as evaluated in the plus maze test and in sucrose preference test, respectively. This altered behavioral phenotype noted at all time points coincided with the decreased striatal DA content in the present study. Since the neural system responsible for the pleasure reward is related to DA release in the ventral striatum in humans and rodents [9] and that both striatal lesion and anhedonia remained present during all points tested in our study, it is tempting to speculate that dopaminergic dysfunction may be related to the anhedonic behavior.
Despite the large involvement of noradrenaline in anxiety and depression disorders [17] , we must concede that our assay was not able to quantify the noradrenaline content, therefore the participation of NA in these responses cannot be ruled out. Additionally, we could not find 5-HT content changes at the second and third week time points. Hence, more studies including the possible contribution of other non-DA neurons are needed to identify the exact participation of these neurotransmitters in anxiety-and depression-like behaviors induced by 6-OHDA.
In 6-OHDA animal models, studies have shown that the degree of motor impairment increases with the 6-OHDA dose [15, 22] . Thus, low doses capable to induce a mild neurodegeneration are less likely to induce motor impairments [15] . Although we found a 60% reduction of dopaminergic striatal content, this level was insufficient to cause a deficit in spontaneous locomotor activity during the second and third weeks post lesion. However, we observed an increased level of striatal 5-HT in the first week, where we also found motor deficits in the plus maze test. It is noteworthy that some studies have reported a decrease in spontaneous locomotor activity of rats as a result of increased 5-HT levels, either by systemic administration of tryptophan [24] or by intraventricular 5-HT injection [12] . Thus, the decrease in locomotor activity, observed 7 days after surgery, may be related to increased levels of striatal 5-HT; this makes the first week after surgery a period of time subject to some type of motor alterations.
Besides the reorganization of striatal neurons, cell death also provokes a response from the innate immune system. A recent study showed that neuronal necrosis can activate microglial cells responsible for proinflammatory responses and is potentially capable of producing a neurotoxic effect [18] . It is important to note that an indirect quantification method based on the presence a lysosomal enzyme (N-acetyl glucosaminidase) in macrophages [3, 29] have been used to evaluate the macrophage accumulation in the CNS [14, 20] . In this connection, we observed increased microglial levels in the first week in the striatum and SN, consistent with previous studies [1, 6] , additionally, our results suggested that 6-OHDA striatal lesion can induce hippocampal microglial activation, as assessed by NAG levels. Therefore, we provide for the first time evidence that proinflammatory responses, as indicated by increased NAG levels in different brain areas, precedes behavioral effects in a 6-OHDA based model of PD.
Conclusions
Using a mild dose of 6-OHDA our results support the hypothesis that retrograde and partial degeneration of dopaminergic neurons in the SN can induce anhedonic-and anxiety-like behavior accompanied by microglial activation in time dependent manner in some brains areas. Therefore, the present evidence can be linked with the early stages symptoms of PD where motor deficit has not truly developed. These findings may also provide additional contributions to better understand the 6-OHDA model.
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